Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

OptiGroup signs a new five-year contract with ISS

OptiGroup has signed a five year contract with ISS for the distribution of facility management and related supplies to the ISS units in Sweden, Norway, Denmark and Finland. The new contract will commence in January 2019, when the current agreement expires. The contract value over the period is estimated to EUR 100 million.  OptiGroup has been the supplier for cleaning material to ISS in the Nordics since 2002 and this marks a continuation of the successful partnership that has been developed over the years. This is a logical contract extension, which has been enabled by OptiGroup’s

CTT Systems announces first airline award for Airbus A350 Business Class humidification system

CTT SYSTEMS AB (“CTT”), the market leader of aircraft humidity control systems, today announces first Business Class cabin humidification award for the Airbus A350-900 aircraft. An anonymous airline has selected humidifiers for flight deck, crew rests and Business Class to be line-fitted by Airbus in its entire A350-900 fleet. The shipset amounts to six humidifiers and totals 20 A350-900s with first delivery scheduled to mid-2019. “It is a breakthrough and major win," commented Peter Landquist, Vice President Sales & Marketing of CTT Systems.  "We are pleased that our proven and highly

Moberg Pharma’s Year-end report to be published on February 13 - Invitation to teleconference

STOCKHOLM, February 6th, 2018 - On February 13th 2018, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Year-end report 2017. Investors, analysts and journalists are hereby invited to participate in a teleconference at 03:00 pm (CET) on the same date.The teleconference will be hosted by Moberg Pharmas’s CEO Peter Wolpert and CFO Anna Ljung. The presentation will be held in English. Date:             February 13th 2017Time:             03:00 pm (CET) To participate in the conference, please dial in on any number below before the start of the call: SE:

Evolution to launch revolutionary new Roulette game and more at ICE 2018

Evolution Gaming, leading provider of Live Casino solutions, is today unveiling a host of new products at ICE 2018 (6–8 February at ExCeL London), including the revolutionary new Lightning Roulette game.Evolution Lightning Roulette is a unique extended Roulette game that is sure to light up the Live Casino experience for Evolution licensees and their players. All the usual Roulette bets are there — and much more. In Lightning Roulette, every game round also features 1–5 randomly generated lucky numbers. Better still, randomly generated lucky payouts of between 50:1 and 500:1 are paid for

Evolution to launch all-new RNG range at ICE 2018

Evolution Gaming, leading provider of Live Casino solutions, is today unveiling its first ever RNG product offering at ICE 2018 (6–8 February at ExCeL London).The product range, called First Person Gaming (FPG) is aimed to redefine RNG tables games by combining the very best of the RNG and Live Casino worlds. As well as superior 3D rendering and animation for an immersive gaming experience, each FPG game features a ‘Go LIVE’ button that transports players directly to an Evolution Live Casino game with a consistent UI and rules across the FPG and Live games. The games will be available in

NOTE’s Year-end Report 2017

Financial performance October–December• Sales increased by 13% to SEK 325.0 (288.2) million.• Operating profit rose to SEK 22.6 (16.5) million.• Operating margin expanded by 1.3 percentage points to 7.0% (5.7%).• Profit after financial items increased to SEK 21.6 (15.1) million.• Profit after tax rose to SEK 17.8 (12.9) million, corresponding to SEK 0.62 (0.45) per share.• Cash flow after investments amounted to SEK 1.8 (3.2) million, or SEK 0.06 (0.11) per share.Financial performance January–December• Sales amounted to SEK 1,175.7 (1,098.1) million. Excluding divestments,

Södra launches pre-painted cladding in twelve colours

As the only supplier in the market, Södra is now offering pre-painted cladding in twelve different colours and several different profiles. Up until now, Södra has offered primed and undercoated cladding in white. Demand for pre-painted cladding has markedly increased, and to meet this need a new, significantly broader concept is now being presented.Together with paint supplier Sherwin-Williams, the twelve most common colours that Swedes paint their houses with have been selected. The cladding, produced in Sweden, is given both primer and an undercoat. Pre-painting increases flexibility in a

Year End Report Scandinavian Enviro Systems AB (publ) January – December 2017

Enviro only qualifier in Chinese government controlled tender process N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.Q4 2017  · Net revenues for the period were MSEK 0.3 (0.1)  · Earnings after tax for the period were MSEK -8.2 (-12.7)   · Earnings per share for the period (before dilution) was SEK -0.07 (-0.13)   · Cash flow for the period after investments was MSEK -4.8 (-10.7)  · Enviro has been elected only finalist in a Chinese,

Interim report January – December 2017

CEO’s comments EQL Pharma has extended the current fiscal year 2017 through 31 March 2018, why the fiscal year will contain five quarters. Therefore, EQL Pharma's year-end report will be presented in conjunction with the Q5 report in May 2018. The period January - December 2017 shows figures that are broadly consistent with our financial targets for the calendar year. During the quarter, EQL Pharma signed a three-year cooperation agreement with a leading generic company regarding the drug Potassium chloride. The cooperation means benefits for EQL Pharma in terms of reduced working

SINGAPORE TAKES NEXT STEP TOWARDS IMPLEMENTING WORLD’S FIRST SPACE-BASED VHF COMMUNICATIONS

The technology will facilitate the safe reduction in separation between aircraftGomSpace A/S (”GomSpace”) a subsidiary of GomSpace Group AB (publ) (the ”Company”) together with The Civil Aviation Authority of Singapore (CAAS) and Singapore Technologies Electronics Limited (ST Electronics) signed a research collaboration agreement on the sidelines of the Singapore Airshow this week, to conduct a design study on the implementation of space-based Very High Frequency (VHF) communications for air traffic management (ATM) in the Singapore Flight Information Region (FIR). This agreement follows

Continued revenue and profitability growth

(Fornebu, 6 February 2018) EVRY is pleased to announce organic revenue growth of 3.7% and an adjusted EBITA margin of 14.5% for the fourth quarter of 2017. Total operating revenue ended at NOK 12,596 million for the full year 2017, with an adjusted EBITA margin of 12.5% as compared to 10.8% in 2016. A dividend of NOK 1,25 per share is proposed.EVRY’s operating revenue in the fourth quarter of 2017 totalled NOK 3,413 million. After adjusting for currency effects and acquisitions and divestments, this is equivalent to an organic revenue growth of 3.7%, compared to 0.3% in the fourth

Interim report Q3 1 April - 31 December 2017

Third quarter (1 October - 31 December 2017) · Net sales increased by 12 percent and amounted to SEK 2,030 million (1,819). · Operating profit before amortisation of intangible non-current assets (EBITA) increased by 19 percent and amounted to SEK 190 million (160) corresponding to an EBITA margin of 9.4 percent (8.8).  · Operating profit increased by 17 percent and amounted to SEK 155 million (132) corresponding to an operating margin of 7.7 percent (7.3). · Profit after tax increased by 17 percent and amounted to SEK 115 million (98) and earnings per share before dilution

CybAero signs collaboration agreement with Missing People

CybAero announces that the company has signed a collaboration agreement today with Missing People Sweden. The agreement allows Missing People to use CybAeros remote controlled drones to find missing people.‘’It is exciting that Missing People has chosen us as a partner in their work to improve their search for missing people. This agreement proves our concept and that our technology attracts bigger interest. It also confirms that our RPAS helicopters can be used in all types of environments’’ says CybAeros CEO Johan Ahlström.When needed, CybAero will provide Missing People with remote

Year-end report January-December 2017

October-December 2017• Net sales for the fourth quarter amounted to SEK 3,116 million (3,155).• Organic growth was 0 per cent (5).• Operating profit amounted to 282 million (297), corresponding to an operating margin of 9.1 per cent (9.4).• Currency effects on operating profit totalled approximately negative SEK 25 million in transaction effects. Translation effects were approximately SEK 0 million.• Profit after tax amounted to 232 million (loss: 264), corresponding to earnings per share after dilution of SEK 1.38 (loss: 1.56).• Operating cash flow amounted to SEK 196 million (

BerGenBio ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast

Bergen, Norway, 06 February 2018 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company focused on developing bemcentinib (BGB324), a first-in-class selective small molecule AXL inhibitor, as a potential cornerstone therapy for multiple cancer indications, will announce its results for the fourth quarter and full year 2017 on Tuesday, 13 February 2018.A presentation by BerGenBio’s senior management team will take place at 10.00 am CET at: Felix Konferansesenter, Bryggetorget 3, 0125 Oslo The presentation will webcast live and the link will be available at www.

IAR Systems Group Year-end-report 2017

NEW ALLIANCES ANDSTRONG FINANCIAL POSITIONNET SALES FOR THE YEAR OF SEK 345M AND EBITDA OF SEK 127MOPERATING MARGIN OF 31% AND CASH FLOW OF SEK 124M FULL-YEAR 2017 · Net sales of SEK 345.0m (328.4) · EBITDA of SEK 127.2m (113.2), corresponding to an EBITDA margin of 36.9% (34.5) ·  Operating profit of SEK 107.4m (96.5), corresponding to an operating margin of 31.1% (29.4) · Profit before tax of SEK 105.7m (96.1) · Basic earnings per share of SEK 6.33 (5.86) and diluted earnings per share of SEK 6.33 (5.86) Earnings per share of SEK 7.32 (7.38) after current tax ·

Samhällsbyggnadsbolaget i Norden AB issues notes for SEK 300 million at a fixed interest rate of 2.9 percent

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) issues senior unsecured notes for SEK 300 million at a fixed interest rate of 2.9% and final maturity date on 20 December 2019. The notes will be issued on 12 February 2018. “We continue to lower our financial costs with this issue which is also our first with a fixed interest rate, something that increases the diversity in our capital structure and our financial flexibility. We are also delighted to once again see continuous support from our institutional investors, which we see as confirmation of the attractive and stable property

Attendo's year-end report 2017 to be published on 15 February - Invitation to teleconference

On 15 February 2018, around 08:00 am (CET), Attendo will present its year-end results of 2017. Investors, analysts and journalists are hereby invited to participate in a teleconference at 10:00 am (CET) on the same date.The teleconference will be hosted by Attendo’s CEO Henrik Borelius and acting CFO Rebecca Ericsson Birck. The presentation will be held in English. Date:             15 February 2018Time:             10:00 am (CET) To participate in the conference, please dial in on any number below at least ten minutes before the start of the call: SE:                +46 8 566

A strong finish to 2017

Fourth quarter · Net sales increased by 3% to SEK 20,109 M (19,484), with organic growth of 5% (1) and acquired net growth of 3% (2) · Strong growth has been exhibited by Global Technologies and EMEA and good growth by Americas, Entrance Systems and Asia Pacific · Contracts have been signed for the acquisition of two companies with combined expected annual sales of about SEK 400 M · Operating income[1] (EBIT) was SEK 3,359 M (2,913), corresponding to an operating margin of 16.7% (15.0) · Net income[1] amounted to SEK 2,385 M (2,088) · Earnings per share[1] amounted to

Nomination Committee’s recommendations to ICA Gruppen’s Annual General Meeting

The Nomination Committee of ICA Gruppen recommends the re-election of board members Göran Blomberg, Jeanette Jäger, Cecilia Daun Wennborg, Andrea Gisle Joosen, Fredrik Hägglund, Bengt Kjell, Magnus Moberg and Anette Wiotti. The Nomination Committee also recommends the reelection of Claes-Göran Sylvén as Chairman of the Board. Jan Olofsson has declined re-election,and the Nomination Committee therefore recommends the new election of Fredrik Persson, chairman of the board at The Confederation of Swedish Enterprise and JM, also member of the board at Electrolux and former CEO of Axel Johnson.

Year-end report 2017 Bactiguard Holding AB

2017 was a good year for Bactiguard. Our objective was to generate growth, with sustained cost control, to approach our long-term financial targets of 20 percent growth and an EBITDA margin of 30 percent. It is therefore gratifying that sales for the full year amounted to close to MSEK 154, which means growth of 20 percent, quite in line with our targets. The EBITDA margin was 22 percent, which is a significant improvement over the 12 percent reported in 2016, but we have some way to go before reaching our profitability target. The growth is mainly related to new licensing deals, but sales of

Tradedoubler year-end report January - December 2017

Steady progress THE FOURTH QUARTER OCTOBER – DECEMBER 2017 · Net sales amounted to SEK 295 M (346). Net sales adjusted for change related items were SEK 295 M (343), which was a decrease of 14%. · Gross profit adjusted for change related items was SEK 66 M (78), a decrease of 16% or 16% adjusted for changes in exchange rates. Gross margin adjusted for change related items was 22.2% (22.7). · Operating costs excluding depreciation and change related items were SEK 61 M (65), a decrease of 7%. · EBITDA amounted to SEK 6 M (-2). Adjusted for change related items, EBITDA was

Castellum’s Annual Report 2017 is now available in Swedish on www.castellum.se

Castellum’s Annual Report 2017 is from now on available in Swedish on castellum.se, Investor Relations section. The printed edition of the Annual Report will be available in mid-February. Castellum’s Annual Report 2017 in English will be available on our website on February 19. This information is information that Castellum is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out below, at 08:00 a.m. (CET) on February 6, 2018. For additional

BONESUPPORT HOLDING AB – Year-end Report January-December 2017 – invitation to conference call and webcast

Lund, Sweden, 08.00 CET, 6 February 2018 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform, will publish its Year-end Report for January-December 2017 on Tuesday 20 February 2018 at 08.00am CET. The Company will also host a conference call and an online presentation on the same day at 10am CET. The dial-in numbers for the conference call are: UK: +442030089808 SE: +46850639549 US: +18557532235 The presentation

There are no items matching the current filter
There are no more items matching the current filter
Back to top